Rep. Schweikert Introduces Legislation to Expedite Advancement of Treatments Targeting Addictive Substances
April 02, 2024
April 02, 2024
WASHINGTON, April 2 -- Rep. David Schweikert, R-Arizona, has issued the following news release on April 1, 2024:
Last week, U.S. Representative David Schweikert (AZ-01) introduced the Substance Therapy Designation Act, legislation that would allow for opioid, cocaine, methamphetamine, and alcohol to be eligible for an FDA breakthrough therapy designation. The designation significantly expedites the development and review of such treatments. On top of that, the bill ensures that the . . .
Last week, U.S. Representative David Schweikert (AZ-01) introduced the Substance Therapy Designation Act, legislation that would allow for opioid, cocaine, methamphetamine, and alcohol to be eligible for an FDA breakthrough therapy designation. The designation significantly expedites the development and review of such treatments. On top of that, the bill ensures that the . . .